Polycystic Ovary Syndrome
Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder among women of reproductive age, characterized by high androgen levels, infertility, cysts on the ovaries, and metabolic abnormalities. While cysts may form on the ovaries, they are not a universal symptom and not the underlying cause of the disorder.
Health Outcomes
- Atherogenic Lipid Profile
- Change in Waist-to-Hip Ratio
- Changed Anti-Müllerian Hormone Level
- Changed Estrogen Level
- Changed Gonadal Hormone Level
- Changed Mid-luteal Progesterone Level
- Changed Plasma Glycerophospholipid Levels
- Changed Pre-ovulatory Luteinizing Hormone Level
- Changed Testosterone Level
- Changed Vaginal Microbiota Composition
- Characterized Carbohydrate Metabolism Enzyme Activity
- Decreased HDL Cholesterol Level
- Distinct Metabolic Profile
- Elevated Hormone Levels
- Elevated Insulin Levels
- Elevated Serum Leptin Levels
- Enhanced AMPK Activation
- Enhanced Hormone Normalization
- Enhanced Insulin Secretion
- Improved Adipocyte Inflammatory Profile
- Improved Adipokine Profile
- Improved Anthropometric Measures
- Improved Assisted Reproductive Outcome
- Improved Biochemical Pregnancy Rate
- Improved Blood Glucose Control
- Improved Cardio-Metabolic Profile
- Improved Clinical Pregnancy
- Improved Clinical Pregnancy Rate
- Improved Cycle Regularity
- Improved Embryo Quality
- Improved Endocrine Function
- Improved Fertility
- Improved Fertility Rate
- Improved Fertilization Rate
- Improved Follistatin Level
- Improved Glucose Homeostasis
- Improved HOMA Index
- Improved HOMA-B
- Improved Hair Score
- Improved Hormonal Balance
- Improved Hormonal Profile
- Improved Hormonal Response
- Improved Hormonal Status
- Improved Hormone Secretion
- Improved Incretin Release
- Improved Insulin Levels
- Improved Insulin Resistance
- Improved Insulin Response
- Improved Insulin Secretion Rate
- Improved Insulin Sensitivity
- Improved LH/FSHormonal Balance
- Improved Laying Performance
- Improved Live Birth Rate
- Improved Maternal Metabolic Health
- Improved Maturation Index
- Improved Menstrual Cycle Regularity
- Improved Menstrual Irregularity
- Improved Metabolic Function
- Improved Metabolic Health
- Improved Metabolic Homeostasis
- Improved Metabolic Indicator
- Improved Metabolic Marker
- Improved Metabolomic Profile
- Improved Obesity Metrics
- Improved Obesity Parameters
- Improved Oocyte Maturity Rate
- Improved Oocyte Recovery
- Improved Ovarian Morphology
- Improved Ovarian Reserve Marker
- Improved Ovulation
- Improved Polycystic Ovary Syndrome
- Improved Pregnancy Rate
- Improved Prognosis of Type 2 Diabetes Mellitus
- Improved Protein Secretion
- Improved Reproductive Health
- Improved Reproductive Health Parameters
- Improved Reproductive Parameter
- Improved Reproductive System Disease
- Improved SHBG Level
- Improved Satiety Hormonal Status
- Improved Satiety Index
- Improved Sex Hormone Balance
- Improved Steroidogenesis
- Improved Total Hair Density
- Improved Weight Loss
- Increased Adipogenesis
- Increased Adipose Browning
- Increased Appendicular Lean Mass
- Increased Birth Weight
- Increased Blood Glucose Levels
- Increased Body Mass
- Increased Body Mass Index
- Increased Body Weight
- Increased Body Weight Gain
- Increased Branched Chain Amino Acid Levels
- Increased C-peptide Level
- Increased Caloric Intake in Females
- Increased Chemical Pregnancy Rate
- Increased Circulating Estradiol Level
- Increased Daily Weight Gain
- Increased Dominant Follicle Count
- Increased Embryo Number
- Increased Endometrial Thickness
- Increased Estradiol Level
- Increased Fasting Insulin Level
- Increased Femoral Neck Bone Mineral Density
- Increased GLP-1 Levels
- Increased Gestational Age
- Increased Glucagon-Like Peptide 1 Level
- Increased Hair Count
- Increased Hair Density
- Increased Hair Diameter
- Increased Insulin Level
- Increased Insulin Resistance Level
- Increased Insulin Response
- Increased Insulin Secretion
- Increased Irisin Level
- Increased LH Level
- Increased Leptin Level
- Increased Leptin Levels
- Increased Luteinizing Hormone Level
- Increased MII Oocyte Count
- Increased Mature Oocyte Number
- Increased Milk Production
- Increased Miscarriage Risk
- Increased Muscle Thickness
- Increased Number of Pregnancies
- Increased Other Serum Hormone Level
- Increased Plasminogen Activator Inhibitor-1 Level
- Increased Preovulatory Follicle Count
- Increased Propionate Production
- Increased Retrieved Oocyte Count
- Increased Serum Insulin Level
- Increased Serum Insulin Levels
- Increased Serum Testosterone Levels
- Increased Serum Triglycerides
- Increased Skeletal Muscle Mass
- Increased Skin Sebum Production
- Increased Testosterone Level
- Increased Testosterone Production
- Increased Total Testosterone
- Increased Vaginal Maturation Index
- Increased Weight Gain
- Increased Weight Gain Post-Challenge
- Increased Weight Gain Rate
- Increased Weight Velocity
- Maintained Breastfeeding Continuation
- Maintained Female Reproductive Tract Homeostasis
- No Change in Body Weight or Cardiometabolic Parameters
- No Change in Body Weight or Food Consumption
- No Change in FSH Level
- No Change in Metabolic Health
- No Change in Overall Glucose Response
- No Change in Serum Triglycerides
- No Significant Change in Androgen Levels
- Normalized Luteal Phase
- Prevention of Weight Gain
- Promoted Weight Gain
- Reduced Abdominal Fat
- Reduced Abnormal Eggs
- Reduced Adipocyte Hypertrophy
- Reduced Adipocyte Senescence
- Reduced Adipokine Level
- Reduced Adiponectin Level
- Reduced Adiposity
- Reduced Adipsin Level
- Reduced Arachidonic Acid to EPA Ratio
- Reduced Asprosin Level
- Reduced Blood Glucose Levels
- Reduced Fasting Insulin Level
- Reduced Fat Gain
- Reduced Fetal Loss
- Reduced Follicle Stimulating Hormone
- Reduced Follicular Fluid Cell-Free DNA Level
- Reduced Free Androgen Index
- Reduced GLP-1 Levels
- Reduced Gestational Diabetes
- Reduced Glucose Tolerance
- Reduced HDL Cholesterol
- Reduced HDL Cholesterol Level
- Reduced HOMA-IR
- Reduced Hair Shaft Diversity
- Reduced Hirsutism Severity
- Reduced Homeostatic Model Assessment for Insulin Resistance
- Reduced Homeostatic Model Assessment-Insulin Resistance Index
- Reduced Incidence of Type 2 Diabetes
- Reduced Inflammation in the Female Reproductive Tract
- Reduced Insulin Resistance
- Reduced Insulin Response
- Reduced Insulin Sensitivity
- Reduced Irisin Level
- Reduced LH-to-FSH Ratio
- Reduced Menstrual Bleeding
- Reduced Mesenteric Adipose Tissue Accumulation
- Reduced Metabolic Disease Risk
- Reduced Metabolic Dysregulation
- Reduced Metabolic Function
- Reduced Metabolic Syndrome Prevalence
- Reduced Miscarriage
- Reduced Number of Broken Eggs
- Reduced Number of Downgraded Eggs
- Reduced Obesity-Related Taxa
- Reduced Ovarian Volume
- Reduced Oxidative Stress Index
- Reduced Oxidative Stress Score
- Reduced Postprandial Blood Glucose
- Reduced Postprandial GLP-1 Level
- Reduced Postprandial Glucose
- Reduced Postprandial Glycemic Response
- Reduced Postprandial Insulin
- Reduced Postprandial Insulin Response
- Reduced Pregnancy Loss
- Reduced Recombinant Human Follicle-Stimulating Hormone Dosage
- Reduced Recurrent Implantation Failure
- Reduced Reproductive Function
- Reduced Resistance Index
- Reduced Risk of Type 2 Diabetes
- Reduced SHBG
- Reduced Sex Hormone-Binding Globulin Level
- Reduced Spontaneous Abortion
- Reduced TMAO Levels
- Reduced Total Antioxidant Capacity
- Reduced Type 2 Diabetes Symptoms
- Reduced Uterine Inflammatory Factors
- Reduced Visfatin Level
- Reduced Waist Circumference
- Reduced Waist-to-Height Ratio
- Regulated Hormone Level
- Regulated Ovulation
- Stable Androgen Levels
- Unchanged Insulin Resistance
- Unchanged Offspring Number
- Weight Gain Consistency